Top developments and predictions in the Life Sciences & Healthcare sector in China (CMS)
Learn about top 2021 developments and 2022 predictions in the Life Sciences & Healthcare sector in China.
Learn about top 2021 developments and 2022 predictions in the Life Sciences & Healthcare sector in China.
Learn about the requirements for employers and with new directives and their states of progress in the EU.
This article includes a review of Wyoming’s attributes as a jurisdiction to base a corporation, limited partnership (“LP”) or
limited liability company (“LLC”), and then reviews Wyoming’s unique (in the United States) laws facilitating company and investment fund formation and investment vehicles focused on cryptocurrencies, digital assets and DAOs.
Risk matrix. This tool is a sample risk matrix for developing a compliance risk inventory from which a ranking of risks can be developed. This is part of the initial phase of compliance risk assessment, followed by the development and implementation of an action plan to control or minimize the risks.
On March 6, 2024, the US Securities and Exchange Commission approved final rules requiring companies to disclose certain climate-related information in registration statements and annual reports.
This resource explains the requirements set forth in the final rules and sets forth practicalities and next steps for compliance.
Check out ACC's selection of curated insights, samples and events in the ACC Privacy and Cybersecurity Resource Center
Learn how public companies in Canada can structure their board, develop policies and procedures, handle disclosure obligations, and recent corporate governance developments.
Explore strategies for effective compliance with US sanctions and export controls affecting trade with China.
This article, developed by Latham & Watkins, covers the new regulatory requirements the US government has been implementing around notifications and disclosures of major cyberattacks and incidents.
Learn about the UK National Security and Investment Act 2021 allowing the UK government to scrutinize and intervene in acquisitions and investments in order to protect national security.